Post-market Safety Reassessment of Ulinastatin for Injection

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-15006751

Enrollment

Unknown

Registered

2015-07-15

Start date

2014-08-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All area

Interventions

general department:Ulinastatin Treat

ICU:Ulinastatin Treat

Eligibility

Sex/Gender

All

Age

No minimum to 100 Years

Inclusion criteria

Inclusion criteria: Patients with ulinastatin treated

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
AE/ADR;	—

Countries

China

Contacts

Public ContactMingjuan Hua

huamj@techpool.com.cn+86 020-38972511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026